Skip to main
Peptides Emporium

Melanotan II, GHK-Cu and the credit each result deserves.

Reading list

The combination trial is the starting point. The wider collection includes the experiments, reviews and harm reports that complicate the names.

Hair, copper and skin

The 5-aminolevulinic acid + GHK trial is the source of the hair-count comparison. The skin-layer experiment measures copper penetration outside the body. Read them alongside the topical delivery review and the skin-regeneration review for the formulation problem and wider topical literature.

The gene-data review concerns a different kind of evidence. Its database and cell findings raise questions that the clinical studies have yet to answer.

Melanotan II sources

The development history supplies the melanocortin lineage. The pigmentation pilot and erectile-function crossover trial supply the small human experiments discussed here; the food-motivation study used mice.

The renal infarction report and oral pigmentation case describe human harms with the limitations of case reports. The social-media analysis addresses promotion and perception. Those sources ask such different questions that a single vote for or against a compound would be a poor way to tally the collection.

Source register

  1. Bonchev A. Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. Life (Basel). 2026;16(2):265. ↗
  2. Eliason NL, Martin L, Low MJ, Sharpe AL. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food. Neuropeptides. 2022;96:102289. ↗
  3. Peters B, Hadimeri H, Wahlberg R, Afghahi H. Melanotan II: a possible cause of renal infarction: review of the literature and case report. CEN Case Rep. 2020;9(2):159-161. ↗
  4. Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006;27(4):921-930. ↗
  5. Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine N. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol. 1998;160(2):389-393. ↗
  6. Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-1784. ↗
  7. Healy E, et al. The 'Barbie Drug'-marketing and perceptions of melanotan on social media. J Eur Acad Dermatol Venereol. 2025;39(2):e106-e107. ↗
  8. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2025;15:30071. ↗
  9. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987. ↗
  10. Lee WJ, Sim HB, Jang YH, Lee SJ, Kim DW, Yim SH. Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth. Annals of Dermatology. 2016;28(4):438-443. ↗
  11. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108. ↗
  12. Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflammation Research. 2011;60(1):79-86. ↗